financetom
Market
financetom
/
Market
/
Aebi Schmidt Makes Nasdaq Debut After Shyft Merger, Stock Surges 47% In After-Hours Trading
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aebi Schmidt Makes Nasdaq Debut After Shyft Merger, Stock Surges 47% In After-Hours Trading
Jul 3, 2025 12:50 AM

Aebi Schmidt Holding AG , the Swiss manufacturer of agricultural machinery, has commenced regular trading on the Nasdaq, following its merger with the U.S.-based Shyft Group ( SHYF ) .

What Happened: The stock of Aebi Schmidt dropped 86.57% to $11.18 on Wednesday during the regular session, after the company started trading on the Nasdaq. The stock closed at $16.41 in after-hours trading, marking a 46.78% increase.

The company’s previous close was $83.26, with a day range of $10.10 to $33.00. The year range was $10.10 to $83.26, with an average volume of 44.00.

See Also: How Trump’s ‘Big Beautiful Bill’ Could Create A ‘Big Beautiful Bull Run’ For Bitcoin, Ethereum, XRP

 The new entity began trading on the Nasdaq on July 1, 2025.

Why It Matters: The Shyft Group ( SHYF ) and Aebi Schmidt Group completed a $2 billion merger, creating a global specialty vehicle leader. The merger was announced in June 2024 and was finalized in July 2025. The merger was approved by Shyft Group ( SHYF ) shareholders in June 2025, after the company received the SEC’s declaration that the registration statement was effective for the new entity to trade on the Nasdaq as “AEBI”.

The merger was a strategic move for both companies, with Shyft Group ( SHYF ) aiming to expand its global presence and Aebi Schmidt seeking to strengthen its position in the U.S. market. 

Read Next: Elon Musk Is 100% Correct, Says Balaji Srinivasan: America Is ‘Broke’ And There Is ‘No Fix’ But Is It A Win-Win For Bitcoin?

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo Courtesy: Sittipong Phokawattana on Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Financial
Sector Update: Financial
Mar 21, 2024
03:19 PM EDT, 03/21/2024 (MT Newswires) -- Financial stocks advanced late Thursday afternoon, with the NYSE Financial Index and the Financial Select Sector SPDR Fund (XLF) each rising 0.9%. The Philadelphia Housing Index climbed 1.8%, and the Real Estate Select Sector SPDR Fund (XLRE) was adding 0.4% Bitcoin (BTC-USD) dropped 4% to $65,176, and the yield for 10-year US Treasuries...
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Mar 22, 2024
(Updates to closing prices) TOKYO, March 22 (Reuters) - Japan's Nikkei share average closed at an all-time high on Friday, underpinned by record gains on Wall Street overnight and strength in automakers' stocks on a weaker yen. The Nikkei rose 0.18% to end at 40,888.43, after hitting 41,087.75 earlier in the session to break an all-time intraday high. The index,...
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Mar 21, 2024
TOKYO, March 22 (Reuters) - Japan's Nikkei share average hit a record high on Friday, underpinned by the strength on Wall Street overnight and as a weaker yen prompted investors to buy automakers. The Nikkei rose to as high as 41,087.75 earlier in the session, crossing the 41,000 level for the first time. The index ended 0.07% higher at 40,844.53...
Sector Update: Health Care
Sector Update: Health Care
Mar 21, 2024
03:42 PM EDT, 03/21/2024 (MT Newswires) -- Health care stocks rose late Thursday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) rising 0.3%. The iShares Biotechnology ETF (IBB) climbed 0.9%. In corporate news, Eledon Pharmaceuticals ( ELDN ) shares surged 12% after it said its tegoprubart monoclonal antibody was used...
Copyright 2023-2026 - www.financetom.com All Rights Reserved